Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at BMO Capital Markets from $64.00 to $22.00. They now have an "outperform" rating on the stock.
MediumReport
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at BMO Capital Markets from $64.00 to $22.00. They now have an "outperform" rating on the stock.
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $20.00. They now have an "outperform" rating on the stock.
HighReport
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $20.00. They now have an "outperform" rating on the stock.
Q32 Bio Inc. (NASDAQ: QTTB) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $22.00 price target on the stock, down previously from $90.00.
HighReport
Q32 Bio Inc. (NASDAQ: QTTB) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $22.00 price target on the stock, down previously from $90.00.
Q32 Bio Inc. (NASDAQ: QTTB) had its "market perform" rating re-affirmed by analysts at Leerink Partners. They now have a $9.00 price target on the stock, down previously from $68.00.
HighReport
Q32 Bio Inc. (NASDAQ: QTTB) had its "market perform" rating re-affirmed by analysts at Leerink Partners. They now have a $9.00 price target on the stock, down previously from $68.00.
Q32 Bio Inc. (NASDAQ: QTTB) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $16.00 price target on the stock, down previously from $95.00.
HighReport
Q32 Bio Inc. (NASDAQ: QTTB) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $16.00 price target on the stock, down previously from $95.00.
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at Piper Sandler from $85.00 to $20.00. They now have an "overweight" rating on the stock.
HighReport
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at Piper Sandler from $85.00 to $20.00. They now have an "overweight" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: